
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF
Updated: 23/09/2026, 16:36:38
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations are structured into five main segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Services, Pharmaceutical Distribution and Retail, and Other Business activities. Within its pharmaceutical portfolio, Fosun Pharma focuses on critical therapeutic areas such as oncology, immune system modulation, metabolic disorders, gastrointestinal conditions, and central nervous system ailments. Beyond its drug offerings, the company also provides a range of medical equipment and diagnostic solutions. Furthermore, SFOSF is involved in delivering healthcare services and managing hospitals, alongside its wholesale and retail distribution of medicines.
No summaries found.
- Share price
- $2.20
- Market cap
- $5.82B
- Exchange
- OTC
- Currency
- USD
- CEO
- Yi Liu
- Employees
- 40,603
- IPO date
- 21/04/2014
- Beta
- 0.437
- Last dividend
- $0.00
- Day range
- $2.20 – $2.20
- 52-week range
- $1.93 – $3.50
- 1-day performance
- 0.00%
- 1-year performance
- 13.87%
- Current drawdown (1Y)
- -37.14%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- CNE100001M79
- Created
- 07/12/2025, 14:11:12
- Last update
- 23/09/2026, 16:36:38
Track Shanghai Fosun Pharmaceutical (Group) Co., Ltd. with an AI analyst
See which prediction-market events move SFOSF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.